GM-CSF Promotes Immune Response and Survival in a Mouse Model of COVID-19

COVID-19 results in increased expression of inflammatory cytokines, but inflammation-targeting clinical trials have yielded poor to mixed results. Our studies of other disorders with an inflammatory component, including Alzheimer’s disease, chemobrain, Down syndrome, normal aging, and West Nile Viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Kendall, L.V., Boyd, T.D., Sillau, S.H., Bosco-Lauth, A., Markham, N., Fong, D., Clarke, P., Tyler, K.L., Potter, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811947/
https://www.ncbi.nlm.nih.gov/pubmed/35118463
http://dx.doi.org/10.21203/rs.3.rs-1213395/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811947/
https://www.ncbi.nlm.nih.gov/pubmed/35118463
http://dx.doi.org/10.21203/rs.3.rs-1213395/v1

Ejemplares similares